#buys #bullish #WallStreet #analysts
$ADC $FIBO $IMGN $MEDP $PZZA $WMT $YETI
These are all Buys if you can manage the risk.
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy
Below is our list for Monday, 5 October, as follows:
Agree Realty Corp. (NYSE:ADC) was resumed in coverage at Raymond James with a Strong Buy rating and an 82 price target. The consensus target is at 76.
Fortress Biotech Inc. (NASDAQ:FBIO) was started with a Buy rating with a 9 price target at Benchmark. The slightly higher consensus target is 9.80.
ImmunoGen Inc. (NASDAQ:IMGN) was raised to Buy from Neutral at Guggenheim. The company is focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer. Its 52-wk trading range is 1.85 – 3.07, and the consensus price target is 6.96.
Medpace Holdings Inc. (NASDAQ:MEDP) was raised to Buy from Hold at Truist, which also set a 135 price. The consensus target price is 119.20.
Papa John’s International Inc. (NASDAQ:PZZA) was started with a Buy rating and a 110 price target at Loop Capital. The consensus target for the pizza giant is at 106.21
Walmart Inc. (NYSE:WMT) was raised to Buy from Hold at DZ Bank, which also set a 157.50 price target. The consensus target is at 146.09.
Yeti Holdings Inc. (NYSE:YETI): this high-end cooler firm that has expanded its portfolio to more everyday items. Shares have a consensus price target at 56.50.
Have a healthy weekend, Keep the Faith!
Paul Ebeling
Latest posts by Paul Ebeling (see all)
- Senate Parliamentarian: Democrats Cannot Include $15/hr Minimum Wage in COVID Relief Bill - February 25, 2021
- Sitting on a Cash Pile 11.0? Early Call: News and Business Information Services Giant Breaks Out - February 25, 2021
- Wall Street’s Key Stock Analysts Research Report, All Buys - February 25, 2021